For the Inventor, By the Inventor

Enter assignee name

Los Angeles, CA, United States of America

Kalypsys, Inc.

USPTO Granted Patents = 17

CIPO Patents = 2

EPO Patents = 3

Trademarks = 5

Forward Citations = 56

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Stewart Alwyn Noble (14 out of 27 patents)

Andrew Shiau (8 out of 11 patents)

James W Malecha (8 out of 41 patents)

4. Steven P Govek (7 out of 34 patents)

5. David J Thomas (5 out of 5 patents)

6. Sergio G Duron (4 out of 17 patents)

7. Mehmet Kahraman (4 out of 34 patents)

8. Andrew K Lindstrom (4 out of 4 patents)

9. Christian Andreus Hassig (4 out of 8 patents)

10. Christopher D Bayne (3 out of 6 patents)

11. Guy Oshiro (3 out of 3 patents)

12. Cunxiang Zhao (3 out of 3 patents)

13. Carmen K Robinson (3 out of 3 patents)

14. Boliang Lou (3 out of 8 patents)

15. Michael Sertic (3 out of 3 patents)

17 patents: Sort by Forward Citations

1. 9078887 - Bicyclic heteroaryl inhibitors of PDE4 (2015-07-14),

2. 8859550 - Heterocyclic inhibitors of histamine receptors for the treatment of disease (2014-10-14),

3. 8569300 - Substituted tetrazolo[1,5-A]pyrazine inhibitors of histamine receptors for the treatment of disease (2013-10-29),

4. 8258154 - Bicyclic heteroaryl inhibitors of PDE4 (2012-09-04),

5. 8138205 - Heteroarylalkoxy-substituted quinolone inhibitors of PDE4 (2012-03-20),

6. 8080566 - Carbazole inhibitors of histamine receptors for the treatment of disease (2011-12-20),

7. 8080563 - Bicyclic heteroaryl inhibitors of PDE4 (2011-12-20),

8. 7915253 - Sulfonyl-substituted bicyclic compounds as modulators of PPAR (2011-03-29),

9. 7863276 - Salts of modulators of PPAR and methods of treating metabolic disorders (2011-01-04),

10. 7834004 - Sulfonyl-substituted bicyclic compounds as modulators of PPAR (2010-11-16),

11. 7825256 - Inducible nitric oxide synthase dimerization inhibitors (2010-11-02),

12. 7745646 - Bicyclic heteroaryl inhibitors of PDE4 (2010-06-29),

13. 7517884 - Sulfonyl-substituted bicyclic compounds as modulators of PPAR (2009-04-14),

14. 7494999 - Sulfonyl-substituted bicyclic compounds as modulators of PPAR (2009-02-24),

15. 7470722 - Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease (2008-12-30),

Kalypsys, Inc. is a leading pharmaceutical company that specializes in drug discovery and development. With a strong focus on innovative technologies, Kalypsys aims to revolutionize the drug discovery process by accelerating the identification and optimization of novel therapeutic candidates. Their cutting-edge platform combines advanced robotics, artificial intelligence, and high-throughput screening to efficiently screen large compound libraries, leading to the discovery of potential new drugs. Kalypsys collaborates with various partners in the pharmaceutical and biotech industries to advance drug development efforts and ultimately improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

17 Patents

#109 in Los Angeles, CA

#4,370 in California

#18,297 in US

#34,825 in the World

Los Angeles, CA, United States of America

Kalypsys, Inc.

Forward Citations = 56

42 inventors:

Stewart Alwyn Noble (14 out of 27 patents)

Andrew Shiau (8 out of 11 patents)

James W Malecha (8 out of 41 patents)

4. Steven P Govek (7 out of 34 patents)

5. David J Thomas (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…